Concorde lands
- 9 April 1994
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 343 (8902) , 866-867
- https://doi.org/10.1016/s0140-6736(94)90002-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Evaluation of the Quality of Life Associated with Zidovudine Treatment in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1994
- Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected PatientsJAMA, 1993
- Zidovudine Now or Later?New England Journal of Medicine, 1993
- Therapy for Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1993
- Immediate versus deferred zidovudineThe Lancet, 1993
- Early AZT Takes a Pounding in French-British 'Concorde' TrialScience, 1993
- Preliminary analysis of the Concorde trialThe Lancet, 1993
- Zalcitabine and didanosineThe Lancet, 1993
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976